Guidehouse has been at the forefront of navigating the coronavirus pandemic’s historic disruption to the commercial operations of pharma-related industries. 

The firm’s work has spanned numerous challenges, as varied as altering commercial practices amid a remote work environment, maintaining an engaged field force, and implementing ongoing compliance considerations.

Join Guidehouse in this conversation to learn how pharmaceutical companies can refine their plans to re-engage with customers - both in the current environment and when restrictions begin to ease.

The discussion will focus on:

• How COVID-19 has changed product launches.

• Re-engaging customer - new perspectives and increasing role of data analytics & artificial intelligence.

• What might lie ahead — during and after the pandemic.

Mark Stevens, Life Sciences Partner at Guidehouse
Nisha Ninan, Managing Consultant at Guidehouse

William Woywod, Managing Consultant at Guidehouse

 

Moderator:

Stephanie Baum, Director of Special Projects at MedCity News